Adamas Pharma Balance Sheet - Annual (NASDAQ:ADMS)

Add to My Stocks
$27.67 $1.82 (7.04%) ADMS stock closing price Apr 19, 2018 (Closing)

A thorough fundamental analysis involves using data from Adamas Pharma balance sheet, apart from other financial statements, to value the business. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Adamas Pharma stock analysis, and provides insights into the firm's financial performance. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Adamas Pharma had a long term debt of $102.64M at the end of 2017. To understand the debt servicing capacity of the company, one needs to look at Adamas Pharma operating cash flow and Adamas Pharma revenue also. Adamas Pharma debt to equity ratio is 1.55.

View latest 10 year balance sheet data to check Adamas Pharma financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Cash91.31M23.73M33.1M61.44M85.61M62.95M
Marketable Securities82.12M89.91M73.69M60.91M--
Receivables--1.28M---
Inventory1.7M-----
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets3.66M2.54M5.1M---
Total Current Assets
179.17M116.98M113.18M123.52M86M64.19M
Property Plant & Equipment5.65M4.49M2.97M1.46M--
Accumulated Depreciation2.52M1.33M----
Net Property Plant & Equipment
3.13M3.15M2.35M1.22M--
Investment & Advances2.99M22.29M13.16M36.36M--
Other Non-Current Assets------
Deferred Charges------
Intangibles------
Deposits & Other Assets------
Total Assets
186.17M142.47M128.74M161.18M86.21M64.3M
Notes Payable-----4M
Accounts Payable3.87M3.58M3.05M3.68M2.09M3.25M
Current Portion Long-Term Debt------
Current Portion Capital Leases------
Accrued Expenses12.38M5.86M8.45M8.59M2.11M1.4M
Income Taxes Payable------
Other Current Liabilities-----29.81M
Total Current Liabilities
16.6M9.74M11.8M12.54M4.21M38.48M
Mortgages------
Deferred Taxes/Income------
Convertible Debt------
Long-Term Debt102.64M-----
Non-Current Capital Leases------
Other Long-Term Liabilities---1.57M6.24M1.7M
Total Liabilities
120.05M10.29M12.55M14.11M10.46M40.18M
Minority Interest------
Preferred Stock----19.14M19.14M
Common Stock Net------
Capital Surplus277.96M254.55M178.47M157.58M77.16M76.44M
Retained Earnings-211.69M-122.2M-62.15M-10.34M-20.57M-71.49M
Treasury Stock------
Other Liabilities-0.16M-0.19M-0.15M-0.18M--
Shareholders Equity66.12M132.18M116.18M147.07M75.75M24.11M
Total Liabilities & Shareholders Equity186.17M142.47M128.74M161.18M86.21M64.3M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Looking at Adamas Pharma historical stock prices and the current Adamas Pharma stock price can tell you how the stock price has moved, whereas the Adamas Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: ADMS total assets, which was at $186.17M for 2017 is a balance sheet item representing value of what Adamas Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Adamas Pharma is $120.05M. Shareholders' equity comes under liabilities as it is money the company owes the holders of ADMS stock.

Adamas Pharma Balance Sheet - Key Ratios

Current ratio
10.79
Debt to equity ratio
1.55
Asset turnover ratio
0.01
Receivables turnover
1
Price to book ratio
5.87